Royal Bank of Canada’s Nurix Therapeutics NRIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.29M | Buy |
113,233
+106,418
| +1,562% | +$1.21M | ﹤0.01% | 3375 |
|
|
2025
Q1 | $81K | Sell |
6,815
-10,938
| -62% | -$130K | ﹤0.01% | 4989 |
|
|
2024
Q4 | $334K | Sell |
17,753
-25,495
| -59% | -$480K | ﹤0.01% | 3959 |
|
|
2024
Q3 | $973K | Buy |
43,248
+37,458
| +647% | +$843K | ﹤0.01% | 3187 |
|
|
2024
Q2 | $121K | Buy |
5,790
+4,626
| +397% | +$96.7K | ﹤0.01% | 4767 |
|
|
2024
Q1 | $17K | Sell |
1,164
-13,759
| -92% | -$201K | ﹤0.01% | 5539 |
|
|
2023
Q4 | $154K | Buy |
14,923
+6,816
| +84% | +$70.3K | ﹤0.01% | 4787 |
|
|
2023
Q3 | $64K | Buy |
8,107
+2,303
| +40% | +$18.2K | ﹤0.01% | 5155 |
|
|
2023
Q2 | $58K | Buy |
5,804
+3,078
| +113% | +$30.8K | ﹤0.01% | 5255 |
|
|
2023
Q1 | $24K | Sell |
2,726
-4,357
| -62% | -$38.4K | ﹤0.01% | 5576 |
|
|
2022
Q4 | $77K | Buy |
7,083
+6,310
| +816% | +$68.6K | ﹤0.01% | 5168 |
|
|
2022
Q3 | $10K | Buy |
773
+420
| +119% | +$5.43K | ﹤0.01% | 5936 |
|
|
2022
Q2 | $4K | Sell |
353
-1,674
| -83% | -$19K | ﹤0.01% | 6271 |
|
|
2022
Q1 | $28K | Sell |
2,027
-5,068
| -71% | -$70K | ﹤0.01% | 5938 |
|
|
2021
Q4 | $205K | Buy |
7,095
+6,786
| +2,196% | +$196K | ﹤0.01% | 4796 |
|
|
2021
Q3 | $9K | Buy |
309
+163
| +112% | +$4.75K | ﹤0.01% | 6477 |
|
|
2021
Q2 | $4K | Sell |
146
-2,044
| -93% | -$56K | ﹤0.01% | 6616 |
|
|
2021
Q1 | $68K | Buy |
2,190
+1,785
| +441% | +$55.4K | ﹤0.01% | 5202 |
|
|
2020
Q4 | $13K | Buy |
405
+305
| +305% | +$9.79K | ﹤0.01% | 5715 |
|
|
2020
Q3 | $3K | Buy |
+100
| New | +$3K | ﹤0.01% | 5758 |
|